178 related articles for article (PubMed ID: 17704657)
1. In-vitro antiproliferative activities and kinase inhibitory potencies of glycosyl-isoindigo derivatives.
Sassatelli M; Bouchikhi F; Aboab B; Anizon F; Fabbro D; Prudhomme M; Moreau P
Anticancer Drugs; 2007 Oct; 18(9):1069-74. PubMed ID: 17704657
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, kinase inhibitory potencies and in vitro antiproliferative activity of isoindigo and 7'-azaisoindigo derivatives substituted by Sonogashira cross-coupling.
Bouchikhi F; Anizon F; Moreau P
Eur J Med Chem; 2009 Jun; 44(6):2705-10. PubMed ID: 19232788
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative activities of isoindigo and azaisoindigo derivatives.
Bouchikhi F; Anizon F; Moreau P
Eur J Med Chem; 2008 Apr; 43(4):755-62. PubMed ID: 17628214
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins.
Akue-Gedu R; Debiton E; Ferandin Y; Meijer L; Prudhomme M; Anizon F; Moreau P
Bioorg Med Chem; 2009 Jul; 17(13):4420-4. PubMed ID: 19477650
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of diversely substituted indolin-2-ones.
Bouchikhi F; Rossignol E; Sancelme M; Aboab B; Anizon F; Fabbro D; Prudhomme M; Moreau P
Eur J Med Chem; 2008 Nov; 43(11):2316-22. PubMed ID: 18313174
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiproliferative activities of diversely substituted glycosyl-isoindigo derivatives.
Sassatelli M; Bouchikhi F; Messaoudi S; Anizon F; Debiton E; Barthomeuf C; Prudhomme M; Moreau P
Eur J Med Chem; 2006 Jan; 41(1):88-100. PubMed ID: 16330129
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
[TBL] [Abstract][Full Text] [Related]
9. Novel 5,7-disubstituted 6-amino-5H-pyrrolo[3,2-b]pyrazine-2,3-dicarbonitriles, the promising protein kinase inhibitors with antiproliferative activity.
Dubinina GG; Platonov MO; Golovach SM; Borysko PO; Tolmachov AO; Volovenko YM
Eur J Med Chem; 2006 Jun; 41(6):727-37. PubMed ID: 16675067
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel 5-substituted indirubins as protein kinases inhibitors.
Beauchard A; Ferandin Y; Frère S; Lozach O; Blairvacq M; Meijer L; Thiéry V; Besson T
Bioorg Med Chem; 2006 Sep; 14(18):6434-43. PubMed ID: 16759872
[TBL] [Abstract][Full Text] [Related]
11. Pim kinase inhibitory and antiproliferative activity of a novel series of meridianin C derivatives.
More KN; Jang HW; Hong VS; Lee J
Bioorg Med Chem Lett; 2014 Jun; 24(11):2424-8. PubMed ID: 24775304
[TBL] [Abstract][Full Text] [Related]
12. Antitumor studies -- part 2: structure-activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase.
Ali HI; Tomita K; Akaho E; Kunishima M; Kawashima Y; Yamagishi T; Ikeya H; Nagamatsu T
Eur J Med Chem; 2008 Jul; 43(7):1376-89. PubMed ID: 18055068
[TBL] [Abstract][Full Text] [Related]
13. Structure-aided optimization of kinase inhibitors derived from alsterpaullone.
Kunick C; Zeng Z; Gussio R; Zaharevitz D; Leost M; Totzke F; Schächtele C; Kubbutat MH; Meijer L; Lemcke T
Chembiochem; 2005 Mar; 6(3):541-9. PubMed ID: 15696597
[TBL] [Abstract][Full Text] [Related]
14. 1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitors.
Al-awar RS; Ray JE; Hecker KA; Huang J; Waid PP; Shih C; Brooks HB; Spencer CD; Watkins SA; Patel BR; Stamm NB; Ogg CA; Schultz RM; Considine EL; Faul MM; Sullivan KA; Kolis SP; Grutsch JL; Joseph S
Bioorg Med Chem Lett; 2004 Jun; 14(12):3217-20. PubMed ID: 15149678
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pp60c-Src tyrosine kinase inhibitory activities of novel indole-3-imine and amine derivatives substituted at N1 and C5.
Kiliç Z; Isgör YG; Olgen S
Arch Pharm (Weinheim); 2009 Jun; 342(6):333-43. PubMed ID: 19475593
[TBL] [Abstract][Full Text] [Related]
16. Development of new fluorescent xanthines as kinase inhibitors.
Kim D; Jun H; Lee H; Hong SS; Hong S
Org Lett; 2010 Mar; 12(6):1212-5. PubMed ID: 20184370
[TBL] [Abstract][Full Text] [Related]
17. Substituted 2-arylbenzothiazoles as kinase inhibitors: hit-to-lead optimization.
Tasler S; Müller O; Wieber T; Herz T; Pegoraro S; Saeb W; Lang M; Krauss R; Totzke F; Zirrgiebel U; Ehlert JE; Kubbutat MH; Schächtele C
Bioorg Med Chem; 2009 Sep; 17(18):6728-37. PubMed ID: 19692247
[TBL] [Abstract][Full Text] [Related]
18. In-vitro antiproliferative activities and kinase inhibitory potencies of meridianin derivatives.
Rossignol E; Debiton E; Fabbro D; Moreau P; Prudhomme M; Anizon F
Anticancer Drugs; 2008 Sep; 19(8):789-92. PubMed ID: 18690090
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitors.
Ramurthy S; Subramanian S; Aikawa M; Amiri P; Costales A; Dove J; Fong S; Jansen JM; Levine B; Ma S; McBride CM; Michaelian J; Pick T; Poon DJ; Girish S; Shafer CM; Stuart D; Sung L; Renhowe PA
J Med Chem; 2008 Nov; 51(22):7049-52. PubMed ID: 18942827
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, protein kinase inhibitory potencies, and in vitro antiproliferative activities of meridianin derivatives.
Giraud F; Alves G; Debiton E; Nauton L; Théry V; Durieu E; Ferandin Y; Lozach O; Meijer L; Anizon F; Pereira E; Moreau P
J Med Chem; 2011 Jul; 54(13):4474-89. PubMed ID: 21623630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
